Geneva Partners’s Amphenol APH Stock Holding History

Geneva Partners’s Portfolio APH Stock Details APH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-77,060	Closed	-$1.69M	–	79
2021 Q4	$1.69M	Buy	77,060 +66,684	+643%	+$1.35M	0.8%	36
2021 Q3	$8.52M	Sell	10,376 -25,284	-71%	-$464K	4.03%	3
2021 Q2	$610K	Buy	+35,660	New	+$602K	0.28%	65
2020 Q1	–	Sell	-16,000	Closed	-$216K	–	49
2019 Q4	$216K	Sell	16,000 -800	-5%	-$10.2K	0.15%	67
2019 Q3	$203K	Sell	16,800 -82,160	-83%	-$947K	0.16%	67
2019 Q2	$1.19M	Buy	98,960 +12,600	+15%	+$152K	0.96%	39
2019 Q1	$1.02M	Sell	86,360 -12,800	-13%	-$143K	0.87%	41
2018 Q4	$1M	Sell	99,160 -9,760	-9%	-$105K	1.16%	33
2018 Q3	$1.28M	Buy	108,920 +52,400	+93%	+$609K	0.98%	37
2018 Q2	$616K	Hold	56,520	–	–	0.49%	59
2018 Q1	$609K	Hold	56,520	–	–	0.5%	55
2017 Q4	$620K	Hold	56,520	–	–	0.46%	63
2017 Q3	$598K	Buy	+56,520	New	+$555K	0.47%	62
2016 Q2	$531K	Buy	+57,520	New	+$414K	0.48%	56

Other funds holding APH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Geneva Partners's APH Position: Q1 2022 in Review

Geneva Partners sold out of Amphenol (APH) in Q1 2022, closing a stake of 77,060 shares — an estimated $1.69M sold.

Geneva Partners first reported a position in APH in Q2 2016 and held it in 14 quarters. The position peaked at $8.52M in Q3 2021. 896 funds tracked by Wall St. Rank hold APH as of Q1 2022.

Geneva Partners reported no remaining Amphenol position as of Q1 2022 after selling out during the quarter.
Geneva Partners sold 77,060 Amphenol shares in Q1 2022, an estimated $1.69M.
Geneva Partners first reported a position in Amphenol in Q2 2016 and held it in 14 quarters.
Geneva Partners's Amphenol position peaked at $8.52M in Q3 2021.
896 funds tracked by Wall St. Rank held Amphenol as of Q1 2022.

Based on Geneva Partners's 13F filing for Q1 2022, filed 3 May 2022.